Caris Life Sciences, Inc. Common Stock CAI
$32.10
-6.50%
at last close
Market Cap$9.70 billion
P/E Ratio—
Div Yield3.74%
Volume3.26M
52-Week Range
$14.19$36.50
Analyst Ratings
- Consensus
- Moderate Buy — 7 Buy · 4 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $29.80 (-7.2% downside)
Key Stats
- Today's Range
- $32.03 – $35.05
- 50-Day Range
- $23.20 – $36.50
- 52-Week Range
- $14.19 – $36.50
- Volume
- 3.26 million shs
- Average Volume
- 3.77 million shs
- Market Cap
- $9.70 billion
- P/E Ratio
- —
- Dividend Yield
- 3.74%
Dividend
- Dividend Yield
- 3.74%
- Annual Dividend
- $1.20
- Payout Ratio
- —
- Ex-Dividend Date
- 2021-09-09
Short Interest
- Short Interest
- 0.13%
- Days to Cover
- 1.21
About Caris Life Sciences, Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Related Stocks
Compare head-to-head: CAI vs NTRA·CAI vs DGX·CAI vs GRAL·CAI vs BLLN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.